General Information of the Compound
| Compound ID |
CP0565820
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(4S)-5-(4-benzoylpiperidin-1-yl)-4-[[5-[2-[(2S)-2-(cyclobutylcarbamoyl)pyrrolidin-1-yl]-2-oxoethoxy]-1-phenylpyrazole-3-carbonyl]amino]-5-oxopentanoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H44N6O8
|
||||||||||||||||||
| Molecular Weight |
712.804
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(n1)-c1ccccc1)C(=O)N1CCC(CC1)C(=O)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H44N6O8/c45-32(43-20-8-15-31(43)37(50)39-27-11-7-12-27)24-52-33-23-30(41-44(33)28-13-5-2-6-14-28)36(49)40-29(16-17-34(46)47)38(51)42-21-18-26(19-22-42)35(48)25-9-3-1-4-10-25/h1-6,9-10,13-14,23,26-27,29,31H,7-8,11-12,15-22,24H2,(H,39,50)(H,40,49)(H,46,47)/t29-,31-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MMFKCRKIICEICG-SMCANUKXSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound